Bio-Path Holdings Operating Income

As of the most recent data (June 2026), BPTH shows a operating income of $-1.8M. That compares with $-7.2M in the prior-year period — up 75.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BPTH's operating income is now $-1.8M (was $-7.2M) — a 75.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Bio-Path Holdings is outperforming or lagging.

Tracking BPTH's operating income over time shows whether Bio-Path Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $-1.8M That compares with $-7.2M in the prior-year period — up 75.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Bio-Path Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-1.8M) with ownership activity and broader fundamentals.

Bio-Path Holdings's operating income is $-1.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.